Keep updated
Get in touch
Canonical ID: NK-7kLe725rdXKJ2WjGWyQYz3 · Entity type: Company (reference)
| Property | Value | Lang | Source dataset | Source ID | First seen | ||
|---|---|---|---|---|---|---|---|
Company:country | us | ir_uani_business_registry | ir-br-co-166b35ba10b7073bdecdd732d7820c498fc91664 | ||||
Company:id | 7502b87a9ec90e6fea182a2ae9d09dfe4313c8f8 | ir_uani_business_registry | ir-br-co-166b35ba10b7073bdecdd732d7820c498fc91664 | ||||
Company:name | Abbott Laboratories | ir_uani_business_registry | ir-br-co-166b35ba10b7073bdecdd732d7820c498fc91664 | ||||
Company:notes | Over the last three presidential administrations, the United States government has granted Abbott Laboratories 46 special licenses to do business in Iran. (New York Times, "Companies with Permission to Bypass Sanctions," 12/24/10) (http://www.nytimes.com/interactive/2010/12/24/world/24-sanctions-list.html) | ir_uani_business_registry | ir-br-co-166b35ba10b7073bdecdd732d7820c498fc91664 | ||||
Company:sector | Medical* | ir_uani_business_registry | ir-br-co-166b35ba10b7073bdecdd732d7820c498fc91664 | ||||
Company:sourceUrl | https://www.unitedagainstnucleariran.com/company/abbott-laboratories | ir_uani_business_registry | ir-br-co-166b35ba10b7073bdecdd732d7820c498fc91664 | ||||
Company:ticker | NYSE: ABT | ir_uani_business_registry | ir-br-co-166b35ba10b7073bdecdd732d7820c498fc91664 | ||||
Company:topics | export.risk | ir_uani_business_registry | ir-br-co-166b35ba10b7073bdecdd732d7820c498fc91664 | ||||
Company:website | http://www.abbott.com/index.htm | ir_uani_business_registry | ir-br-co-166b35ba10b7073bdecdd732d7820c498fc91664 | ||||